BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

510 related articles for article (PubMed ID: 16900407)

  • 1. Weekly administration of folic acid and epidemiology of neural tube defects.
    Martínez de Villarreal LE; Arredondo P; Hernández R; Villarreal JZ
    Matern Child Health J; 2006 Sep; 10(5):397-401. PubMed ID: 16900407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decline of neural tube defects cases after a folic acid campaign in Nuevo León, México.
    Martínez de Villarreal L; Pérez JZ; Vázquez PA; Herrera RH; Campos Mdel R; López RA; Ramírez JL; Sánchez JM; Villarreal JJ; Garza MT; Limón A; López AG; Bárcenas M; García JR; Domínguez AS; Nuñez RH; Ayala JL; Martínez JG; González MT; Alvarez CG; Castro RN
    Teratology; 2002 Nov; 66(5):249-56. PubMed ID: 12397633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are encephaloceles neural tube defects?
    Rowland CA; Correa A; Cragan JD; Alverson CJ
    Pediatrics; 2006 Sep; 118(3):916-23. PubMed ID: 16950981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High potential for reducing folic acid-preventable spina bifida and anencephaly, and related stillbirth and child mortality, in Ethiopia.
    Dixon M; Kancherla V; Magana T; Mulugeta A; Oakley GP
    Birth Defects Res; 2019 Nov; 111(19):1513-1519. PubMed ID: 31424635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in neural tube defects 1980-1989.
    Bower C; Raymond M; Lumley J; Bury G
    Med J Aust; 1993 Feb; 158(3):152-4. PubMed ID: 8450777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of folic acid for prevention of spina bifida and other neural tube defects--1983-1991.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1991 Aug; 40(30):513-6. PubMed ID: 2072886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neural tube defects: Prevalence, mortality, and maternal characteristics in two departmental hospitals in the northwestern region of Nicaragua, 2006-2018.
    Pastora Bucardo DM; González F; Montes Pastora M; Pimienta Ramirez PA; Bonilla IL; Vielot NA; Finnell RH
    Birth Defects Res; 2023 May; 115(9):945-953. PubMed ID: 37025002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From the Centers for Disease Control. Use of folic acid for prevention of spina bifida and other neural tube defects--1983-1991.
    JAMA; 1991 Sep; 266(9):1190-1. PubMed ID: 1870237
    [No Abstract]   [Full Text] [Related]  

  • 9. [Impact of the fortification of food with folic acid on neural tube defects in Costa Rica].
    Barboza Argüello Mde L; Umaña Solís LM
    Rev Panam Salud Publica; 2011 Jul; 30(1):1-6. PubMed ID: 22159644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival of infants with neural tube defects in the presence of folic acid fortification.
    Bol KA; Collins JS; Kirby RS;
    Pediatrics; 2006 Mar; 117(3):803-13. PubMed ID: 16510661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Audit of Neural Tube Defects in the Republic Of Ireland for 2012-2015.
    McDonnell R; Delany V; O'Mahony MT; Lynch C; McKeating A; McKeating A; Turner MJ
    Ir Med J; 2018 Mar; 111(3):712. PubMed ID: 30376230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 2015 global update on folic acid-preventable spina bifida and anencephaly.
    Arth A; Kancherla V; Pachón H; Zimmerman S; Johnson Q; Oakley GP
    Birth Defects Res A Clin Mol Teratol; 2016 Jul; 106(7):520-9. PubMed ID: 27418029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Countries with an immediate potential for primary prevention of spina bifida and anencephaly: Mandatory fortification of wheat flour with folic acid.
    Kancherla V
    Birth Defects Res; 2018 Jul; 110(11):956-965. PubMed ID: 29532629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of spina bifida and anencephaly during the transition to mandatory folic acid fortification in the United States.
    Williams LJ; Mai CT; Edmonds LD; Shaw GM; Kirby RS; Hobbs CA; Sever LE; Miller LA; Meaney FJ; Levitt M
    Teratology; 2002 Jul; 66(1):33-9. PubMed ID: 12115778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neural defect prevalence in 248,352 consecutive newborns].
    Hernández-Herrera RJ; Alcalá-Galván LG; Flores-Santos R
    Rev Med Inst Mex Seguro Soc; 2008; 46(2):201-4. PubMed ID: 19133193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. When will we eliminate folic acid-preventable spina bifida?
    Oakley GP
    Epidemiology; 2007 May; 18(3):367-8. PubMed ID: 17435446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of wheat flour fortification with folic acid on the prevalence of neural tube defects in Chile].
    Nazer H J; Cifuentes O L
    Rev Med Chil; 2013 Jun; 141(6):751-7. PubMed ID: 24121578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing the prevalence of spina bifida and encephalocele in a Kenyan hospital from 2005-2010: implications for a neural tube defects surveillance system.
    Githuku JN; Azofeifa A; Valencia D; Ao T; Hamner H; Amwayi S; Gura Z; Omolo J; Albright L; Guo J; Arvelo W
    Pan Afr Med J; 2014; 18():60. PubMed ID: 26113894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventable spina bifida and anencephaly in Europe.
    Obeid R; Pietrzik K; Oakley GP; Kancherla V; Holzgreve W; Wieser S
    Birth Defects Res A Clin Mol Teratol; 2015 Sep; 103(9):763-71. PubMed ID: 26178749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A global update on the status of prevention of folic acid-preventable spina bifida and anencephaly in year 2020: 30-Year anniversary of gaining knowledge about folic acid's prevention potential for neural tube defects.
    Kancherla V; Wagh K; Priyadarshini P; Pachón H; Oakley GP
    Birth Defects Res; 2022 Dec; 114(20):1392-1403. PubMed ID: 36345648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.